Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nikpour

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Internal Medicine Journal|May 15, 2013
Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?M Nikpour, W Stevens, S M Proudman, et al.
Medicine|September 2, 2016
Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associationsS Hoa, M Hudson, Y Troyanov, et al.
Internal Medicine Journal|April 28, 2006
Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosusA B Lee, T Godfrey, K G Rowley, et al.
Scandinavian Journal of Rheumatology|April 14, 2021
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patientsAys Lee, K A Patterson, D J Tan, et al.
Arthritis Research & Therapy|June 25, 2024
The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomesA Quinlivan, D Neuen, D Hansen, et al.
Internal Medicine Journal|September 5, 2015
Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosisA Quinlivan, V Thakkar, W Stevens, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components AnalysisK A Patterson, P J Roberts-Thomson, S Lester, et al.
Clinical and Experimental Rheumatology|February 26, 2014
The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisK B Morrisroe, W Stevens, H Nandurkar, et al.
Lupus|November 14, 2019
Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosusR Kandane-Rathnayake, J R Kent, W Louthrenoo, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Internal Medicine Journal|May 15, 2013
Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?M Nikpour, W Stevens, S M Proudman, et al.
Medicine|September 2, 2016
Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associationsS Hoa, M Hudson, Y Troyanov, et al.
Internal Medicine Journal|April 28, 2006
Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosusA B Lee, T Godfrey, K G Rowley, et al.
Scandinavian Journal of Rheumatology|April 14, 2021
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patientsAys Lee, K A Patterson, D J Tan, et al.
Arthritis Research & Therapy|June 25, 2024
The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomesA Quinlivan, D Neuen, D Hansen, et al.
Internal Medicine Journal|September 5, 2015
Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosisA Quinlivan, V Thakkar, W Stevens, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components AnalysisK A Patterson, P J Roberts-Thomson, S Lester, et al.
Clinical and Experimental Rheumatology|February 26, 2014
The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisK B Morrisroe, W Stevens, H Nandurkar, et al.
Lupus|November 14, 2019
Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosusR Kandane-Rathnayake, J R Kent, W Louthrenoo, et al.
Pageof 4